Literature DB >> 23777334

Inducing cancer cell death by targeting its nucleus: solid gold nanospheres versus hollow gold nanocages.

Megan A Mackey1, Farhat Saira, Mahmoud A Mahmoud, Mostafa A El-Sayed.   

Abstract

Recently, we have shown that targeting the cancer cell nucleus with solid gold nanospheres, using a cancer cell penetrating/pro-apoptotic peptide (RGD) and a nuclear localization sequence peptide (NLS), inhibits cell division, thus leading to apoptosis. In the present work, flow cytometric analysis revealed an increase in cell death, via apoptosis and necrosis, in HSC cells upon treatment with peptide-conjugated hollow gold nanocages, compared to those treated with the peptide-conjugated solid gold nanospheres. This is consistent with a G0/G1 phase accumulation, S phase depletion, and G2/M phase depletion, as well as reduced ATP levels. Here, we investigate the possible causes for the observed enhanced cell death with the use of confocal microscopy. The fluorescence images of HSC cells treated with gold nanocages indicate the presence of reactive oxygen species, known to cause apoptosis. The formation of reactive oxygen species observed is consistent with a mechanism involving the oxidation of metallic silver on the inner cavity of the nanocage (inherent to the synthesis of the gold nanocages) to silver oxide. This oxidation is confirmed by an observed redshift in the surface plasmon resonance of the gold nanocages in cell culture medium. The silver oxide, a semiconductor known to photochemically generate hydroxyl radicals, a form of reactive oxygen species, is proposed as a mechanism for the enhanced cell death caused by gold nanocages. Thus, the enhanced cell death, via apoptosis and necrosis, observed with peptide-conjugated hollow gold nanocage-treated cells is considered to be a result of the metallic composition (silver remaining on the inner cavity) of the nanocage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23777334      PMCID: PMC3910495          DOI: 10.1021/bc300592d

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  42 in total

Review 1.  NLS bioconjugates for targeting therapeutic genes to the nucleus.

Authors:  Virginie Escriou; Marie Carrière; Daniel Scherman; Pierre Wils
Journal:  Adv Drug Deliv Rev       Date:  2003-02-10       Impact factor: 15.470

2.  Multifunctional gold nanoparticle-peptide complexes for nuclear targeting.

Authors:  Alexander G Tkachenko; Huan Xie; Donna Coleman; Wilhelm Glomm; Joseph Ryan; Miles F Anderson; Stefan Franzen; Daniel L Feldheim
Journal:  J Am Chem Soc       Date:  2003-04-23       Impact factor: 15.419

3.  Comparative study of photothermolysis of cancer cells with nuclear-targeted or cytoplasm-targeted gold nanospheres: continuous wave or pulsed lasers.

Authors:  Xiaohua Huang; Bin Kang; Wei Qian; Megan A Mackey; Po C Chen; Adegboyega K Oyelere; Ivan H El-Sayed; Mostafa A El-Sayed
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

4.  The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells.

Authors:  Eun Chul Cho; Leslie Au; Qiang Zhang; Younan Xia
Journal:  Small       Date:  2010-02-22       Impact factor: 13.281

5.  Different integrins mediate cell spreading, haptotaxis and lateral migration of HaCaT keratinocytes on fibronectin.

Authors:  L Koivisto; K Larjava; L Häkkinen; V J Uitto; J Heino; H Larjava
Journal:  Cell Adhes Commun       Date:  1999

Review 6.  Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.

Authors:  M van Engeland; L J Nieland; F C Ramaekers; B Schutte; C P Reutelingsperger
Journal:  Cytometry       Date:  1998-01-01

7.  Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro.

Authors:  H Xue; A Atakilit; W Zhu; X Li; D M Ramos; R Pytela
Journal:  Biochem Biophys Res Commun       Date:  2001-11-02       Impact factor: 3.575

8.  The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.

Authors:  S P Crouch; R Kozlowski; K J Slater; J Fletcher
Journal:  J Immunol Methods       Date:  1993-03-15       Impact factor: 2.303

9.  Signal-mediated nuclear transport in simian virus 40-transformed cells is regulated by large tumor antigen.

Authors:  C M Feldherr; R E Lanford; D Akin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles.

Authors:  D Patrick O'Neal; Leon R Hirsch; Naomi J Halas; J Donald Payne; Jennifer L West
Journal:  Cancer Lett       Date:  2004-06-25       Impact factor: 8.679

View more
  18 in total

1.  Plasmonic Nanoparticles: Advanced Researches (II).

Authors:  Hyejin Chang; Sang Hun Lee; Jaehi Kim; Won-Yeop Rho; Xuan-Hung Pham; Dae Hong Jeong; Bong-Hyun Jun
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Present and Future of Surface-Enhanced Raman Scattering.

Authors:  Judith Langer; Dorleta Jimenez de Aberasturi; Javier Aizpurua; Ramon A Alvarez-Puebla; Baptiste Auguié; Jeremy J Baumberg; Guillermo C Bazan; Steven E J Bell; Anja Boisen; Alexandre G Brolo; Jaebum Choo; Dana Cialla-May; Volker Deckert; Laura Fabris; Karen Faulds; F Javier García de Abajo; Royston Goodacre; Duncan Graham; Amanda J Haes; Christy L Haynes; Christian Huck; Tamitake Itoh; Mikael Käll; Janina Kneipp; Nicholas A Kotov; Hua Kuang; Eric C Le Ru; Hiang Kwee Lee; Jian-Feng Li; Xing Yi Ling; Stefan A Maier; Thomas Mayerhöfer; Martin Moskovits; Kei Murakoshi; Jwa-Min Nam; Shuming Nie; Yukihiro Ozaki; Isabel Pastoriza-Santos; Jorge Perez-Juste; Juergen Popp; Annemarie Pucci; Stephanie Reich; Bin Ren; George C Schatz; Timur Shegai; Sebastian Schlücker; Li-Lin Tay; K George Thomas; Zhong-Qun Tian; Richard P Van Duyne; Tuan Vo-Dinh; Yue Wang; Katherine A Willets; Chuanlai Xu; Hongxing Xu; Yikai Xu; Yuko S Yamamoto; Bing Zhao; Luis M Liz-Marzán
Journal:  ACS Nano       Date:  2019-10-08       Impact factor: 15.881

3.  Chemosensitization of cancer cells via gold nanoparticle-induced cell cycle regulation.

Authors:  Megan A Mackey; Mostafa A El-Sayed
Journal:  Photochem Photobiol       Date:  2014-02-11       Impact factor: 3.421

Review 4.  The optical, photothermal, and facile surface chemical properties of gold and silver nanoparticles in biodiagnostics, therapy, and drug delivery.

Authors:  Lauren A Austin; Megan A Mackey; Erik C Dreaden; Mostafa A El-Sayed
Journal:  Arch Toxicol       Date:  2014-06-04       Impact factor: 5.153

Review 5.  Off to the organelles - killing cancer cells with targeted gold nanoparticles.

Authors:  Mohamed Kodiha; Yi Meng Wang; Eliza Hutter; Dusica Maysinger; Ursula Stochaj
Journal:  Theranostics       Date:  2015-01-21       Impact factor: 11.556

6.  Biological Targeting of Plasmonic Nanoparticles Improves Cellular Imaging via the Enhanced Scattering in the Aggregates Formed.

Authors:  Mena Aioub; Bin Kang; Megan A Mackey; Mostafa A El-Sayed
Journal:  J Phys Chem Lett       Date:  2014-07-05       Impact factor: 6.475

7.  Treatment of natural mammary gland tumors in canines and felines using gold nanorods-assisted plasmonic photothermal therapy to induce tumor apoptosis.

Authors:  Moustafa R K Ali; Ibrahim M Ibrahim; Hala R Ali; Salah A Selim; Mostafa A El-Sayed
Journal:  Int J Nanomedicine       Date:  2016-09-22

Review 8.  Biological mechanisms of gold nanoparticle radiosensitization.

Authors:  Soraia Rosa; Chris Connolly; Giuseppe Schettino; Karl T Butterworth; Kevin M Prise
Journal:  Cancer Nanotechnol       Date:  2017-02-02

Review 9.  Nanotechnology in dentistry: prevention, diagnosis, and therapy.

Authors:  Ensanya Ali Abou Neel; Laurent Bozec; Roman A Perez; Hae-Won Kim; Jonathan C Knowles
Journal:  Int J Nanomedicine       Date:  2015-10-08

Review 10.  Standards and Methodologies for Characterizing Radiobiological Impact of High-Z Nanoparticles.

Authors:  Anna Subiel; Reece Ashmore; Giuseppe Schettino
Journal:  Theranostics       Date:  2016-06-20       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.